Interestingly, the stratified analysis found a very poor survival in association with high expression values of TSSC1 gene among patients with clinical characteristics similar to those of our patient, i.e., metastatic disease, age > 18 months, and MYCN amplified. The gene discussed is EIPR1; the disease is metastatic neoplasm.